CRISPR 技术市场规模、份额、成长分析（按产品、应用、最终用户和地区）—2025 年至 2032 年产业预测

2023 年 CRISPR 技术市场规模价值为 35 亿美元，预计将从 2024 年的 40.8 亿美元成长到 2032 年的 138.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 16.5%。

CRISPR 技术（成簇的规律间隔的短回文重复序列）彻底改变了基因编辑，使对任何 DNA 序列进行精确修改成为可能。这项特性使得纠正基因缺陷、消除疾病、提高作物产量品质成为可能。利用合成的嚮导RNA和Cas9核酸酶，研究人员可以透过精确的切割进行有针对性的基因组修饰，从而有效地彻底改变基因编辑方法。全球 CRISPR 市场受到微生物应用日益增长以及公共和私人对基因组研究的大量投资的推动。此外，遗传疾病的流行正在推动对 CRISPR 应用的需求，尤其是在作物改良方面。然而，CRISPR 技术的伦理问题和有限的专业知识带来的挑战可能会在短期内影响市场成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析

CRISPR 技术市场规模（依产品及服务）及复合年增长率（2025-2032）

• 市场概览
• 产品
  • CRISPR套件和酶
  • CRISPR文库
  • 其他产品
  • 设计工具
  • 抗体
  • 其他试剂
• 服务
  • GRNA设计与载体构建
  • 细胞株工程
  • 筛检服务
  • 其他服务
  • 表观基因编辑
  • 转录活化

CRISPR 技术市场规模：按应用和复合年增长率（2025-2032）

• 市场概览
• 药物研发
• 农业
• 其他用途
  • 生质燃料
  • 兽医

CRISPR 技术市场规模（依最终用户和复合年增长率）(2025-2032)

• 市场概览
• 製药和生物技术公司
• 学术研究所
• 其他的
  • CRO
  • CDMOs

CRISPR 技术市场规模：按地区和复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• CRISPR Therapeutics（Switzerland/USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Beam Therapeutics（USA）
• Mammoth Biosciences（USA）
• Caribou Biosciences（USA）
• Synthego（USA）
• ERS Genomics（Ireland）
• Takara Bio（Japan）
• Merck KGaA（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（Integrated DNA Technologies（IDT））（USA）
• Horizon Discovery（PerkinElmer Inc.）（UK/USA）
• GenScript（USA）
• Agilent Technologies（USA）
• New England Biolabs（USA）
• Cellectis（France）
• Sangamo Therapeutics（USA）
• Addgene（USA）
• Biocytogen Co., Ltd.（China）

结论和建议

CRISPR Technology Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 4.08 billion in 2024 to USD 13.84 billion by 2032, growing at a CAGR of 16.5% during the forecast period (2025-2032).

CRISPR technology, or Clustered Regularly Interspaced Short Palindromic Repeats, has revolutionized genetic editing by allowing precise modifications to any DNA sequence. This capability enables the correction of genetic defects, disease elimination, and enhancement of crop yield quality. By utilizing synthetic guide RNA and Cas9 nuclease, researchers can create targeted genome alterations through precise cuts, effectively transforming genetic editing methodologies. The global CRISPR market is significantly driven by increased microbiological applications and substantial public and private investments in genome research. Additionally, the prevalence of genetic diseases heightens the demand for CRISPR applications, particularly in crop improvement. However, ethical issues and limited expertise in CRISPR technology pose challenges that may impact market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR Technology Market

Several factors are driving the growth of the CRISPR technology market, particularly in developed regions like North America and Europe, where increased funding for genetic research is prevalent. Significant investments from government agencies in the United States are enhancing advancements in materials, equipment, and methodologies related to genetic research. This financial support plays a crucial role in fostering medical breakthroughs, particularly for rare genetic diseases. Furthermore, European markets are reaping the benefits of genomic research funding initiatives, such as those provided by the National Human Genome Research Institute, further promoting innovation and progress within the CRISPR industry.

Restraints in the CRISPR Technology Market

The CRISPR Technology market faces significant restraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing innovative genome editing solutions requires substantial investment of time and resources. Although the potential applications of CRISPR gene detection and diagnostic assay kits, as well as therapeutic treatments, are extensive, these expenses ultimately fall upon patients, limiting accessibility. The financial burden can hinder the widespread adoption of CRISPR technologies, posing challenges for both patients seeking treatment and providers aiming to develop effective, affordable genome editing tools. This economic barrier is a critical concern affecting the growth of the market.

Market Trends of the CRISPR Technology Market

The CRISPR technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML), enhancing the efficiency and precision of gene editing processes. This synergy allows for superior target identification and off-target prediction, significantly streamlining research in drug discovery and diagnostics. As AI and ML tools enable rapid analysis of vast datasets, they facilitate the identification of therapeutic targets, leading to more effective treatments and innovations in genetic research. Consequently, the convergence of these technologies is propelling the CRISPR market forward, aligning with a broader shift towards automation and intelligence in biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations